Interpretation of Pharmacovigilance Disproportionality Analyses

Clin Pharmacol Ther. 2023 Oct;114(4):745-746. doi: 10.1002/cpt.2951. Epub 2023 May 30.

Authors

Charles Khouri^{1

2}, Michele Fusaroli³, Francesco Salvo^{4

5}, Emanuel Raschi³

Affiliations

¹ Pharmacovigilance Unit, Grenoble Alpes University Hospital, Grenoble, France.
² Inserm U1300, HP2 Laboratory, Univ. Grenoble Alpes, Grenoble, France.
³ Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
⁴ INSERM, BPH, U1219, Team AHeaD, Univ. Bordeaux, Bordeaux, France.
⁵ Pôle de Santé Publique, Service de Pharmacologie Médicale, CHU de Bordeaux, Bordeaux, France.

PMID: 37248829
DOI: 10.1002/cpt.2951

No abstract available

Publication types

Letter
Comment

MeSH terms

Adverse Drug Reaction Reporting Systems*
Databases, Factual
Humans
Pharmacovigilance*